Table I.
Test Formulations Prepared for In Vivo Testing
| Formulation ID | Dosage form | Dosage strength (mg) | Capsule/tablet size (mm) | Formulation type |
|---|---|---|---|---|
| F1 | Capsule | 30 | 18 × 6.4 (#2) | CyA-SMEDDS filled capsule |
| F2 | Tablet | 30 | Ø 10 | LLT-1 tablet loaded with CyA-SMEDDS. Dose weight: 424 mg |
| F3 | Capsule | 25 | 13 × 7.5 | Neoral® soft gelatin capsule |
| F4 | Capsule | 25 | 18 × 6.4 (#2) | CyA-SMEDDS filled capsule |
| F5 | Capsule | 25 | 26 × 9.9 (#000) | MAMS powder loaded with CyA-SMEDDS |
| F6 | Tablet | 25 | Ø 12 | LLT-2 tablet loaded with CyA-SMEDDS. Dose weight, 514 mg |